New to the forum? Sign Up Here! Already a member? Please login below.
|
|||||
|
||
|
I have never heard of clotting abnormalities mandating specific embryo culture conditions, so its wierd to me too. |
||
|
||
|
Thank you so much for your prompt reply Dr Smith :) |
||
|
||
|
I think I better defer to Dr Jacob at this point. He would be more familiar with the drug treatments for these kind of clotting disorders. |
||
|
||
|
Thank you for all your help Dr Smith, I'm very grateful to you :) |
||
|
||
|
Dear Dr Smith, |
||
|
||
|
Ahh, the lightbulb above my head is now dimly lit. I think they may have been talking about the use of hyaluronan (a long-chain, naturally ocurring, polysaacharide) added to G-2 medium for embryo transfer. There is a commercially available product in the US called "Embryo Glue", manufactured by VitroLife. At least in VitroLife's sponsored studies, Embryo Glue was shown to have a benificial effect on implantation. This may have been due to a molecular bridging effect between the embryo and the endometrium facilitated by hyalronan or hyaluronan's ability to increase the viscosity of the transfer medium (the embryos stay where you put them after transfer). There have been no independent, large scale, clinical studies to support this notion. However, I've been using Embryo Glue as a blastocyst transfer medium for about 3 years and we saw a small, but significant, increase in implantation rate after we started using it. We never published these findings because I do not believe in promoting any particular product. |
||
|
||
|
Thank you so much for the info on "Embryo Glue" Dr Smith :) |
||
|
||
|
"Embryo Glue" was designed as a embryo transfer medium. The composition of the medium is appropriate for the nutritional requirements of embryos that have reached the 8-cell stage or beyond (i.e. morula, blastocyst). It was not designed for embryo culture from Day 1-2 and may compromise development. I wouldn't recommend it. Sorry. |
||
|
||
|
Thank you for letting me that know Dr Smith. |
||
|
||
|
In a sequential media culture system, one medium formulation is used for fertilization (Day 0-1), another media formulation for Days 2-3, a third media formulation for Days 3-5(or 6) and then a final media containing hyaluronan (Embryo Glue) for the transfer of the blastocyst stage embryo. These media formulations are designed to meet the stage-specific nutritional requirements of the sperm, eggs and embryos throughout development to the blastocyst stage. The formulations are based on years of scientific research directed toward understanding human sperm, egg and embryo metabolism. Thankfully, gone are the days of "guess work". However, as research in this field proceeds at break-neck speed, these are formulations are revised regularly as new information become available. |
||
|
||
|
|
||
|
||
|
When culturing to the blastocyst stage, embryo culture conditions do play a part. In the US where sequential culture systems are readily available and emplyed, it is not a big issue. The G-series media manufactured by Vitrolife, including Embryo Glue, is distributed in the UK through: |
||
|
||
|
Thank you so much again for getting back to me so quickly Dr Smith :) |
||
|
||
|
I am not a geneticist, so I'm talking out of turn here. I'll tell what I know, but for a real, scientific answer, perhaps you should consult a genetic counsellor. We have successfully treated individuals with your clotting disorder mutations. They are not that uncommon in the repeat IVF failure group. When I reviewed the embryology reports for these cases, I did not see anything abnormal about the embryo development (i.e. normal blastocyst development for their age). So, as far as I can tell, there is no link between these mutations and embryo development per se. The impact of these mutations appears to be entirely post-implantation and from the uterine side of the equation. |
||